Illumina president and CEO Francis deSouza (Photo by Kevin Dietsch/Getty Images)

EU set to launch full-scale in­ves­ti­ga­tion in­to Grail-Il­lu­mi­na deal amid an­titrust con­cerns — re­port

The pro­posed $8 bil­lion merg­er be­tween liq­uid biop­sy firm Grail and can­cer blood screen­ing gi­ant Il­lu­mi­na has met with noth­ing but flack since it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.